A novel model to study COVID-19 and Hypertension
研究 COVID-19 和高血压的新模型
基本信息
- 批准号:10428648
- 负责人:
- 金额:$ 19.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-14 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVACE2AddressAnimal ModelAnimalsAntihypertensive AgentsBlood PressureCOVID-19COVID-19 pandemicCOVID-19 pathogenesisCOVID-19 severityCOVID-19 therapeuticsCOVID-19 vaccineCOVID-19 vaccine evaluationCRISPR/Cas technologyCommunitiesContractsDahl Hypertensive RatsDataDevelopmentDietDietary SodiumEtiologyExperimental ModelsFelis catusFerretsGene ExpressionGenesGerm-FreeHamstersHandHumanHypertensionIndividualIntakeK-18 conjugateKnock-inKnock-outKnowledgeLightMedicalModelingMusNamesOrganPathogenesisPathologyPatientsPlayPredispositionPublishingRattusReportingResearchRiskRoleSARS-CoV-2 infectionSARS-CoV-2 transmissionSodium ChlorideSodium-Restricted DietStudy modelsSymbiosisTestingTherapeuticTimeTransgenic MiceVirusVirus SheddingWorkanimal databasedesigndietary saltdysbiosiseffectiveness evaluationfecal transplantationgut microbiotahigh riskhigh salt diethost microbiotahypertensivehypertensivesin vivointerestmicrobialmicrobiotanonhuman primatenovelnovel coronavirusprotein expressionreceptorsalt sensitivesalt sensitive hypertensionsexvaccine development
项目摘要
7. Project Summary/Abstract
Animal models fare indispensable for understanding the pathology of COVID-19 as well as for developing
vaccines. They are also important to discern the etiology of COVID-19 in specific groups at risk, such as
individuals with pre-existing hypertension. While there are hamsters, ferrets, cats, nonhuman primates and K18-
hACE2 transgenic mice as possible models for studying COVID-19, none serves the purpose of studying the
relationship between hypertension and susceptibility to COVID-19 because (1) wild-type research models do not
get infected with the human SARS-CoV-2 and/or (2) they are not genetically prone to hypertension. To fill this
unmet need, we propose to develop in vivo experimental platform for studying COVID-19 in the setting of
hypertension. In preliminary data, we present evidence for the development of a novel knock-in rat model of the
hypertensive Dahl Salt-sensitive (S) rat edited using the CRISPR/Cas9 technology to express the human ACE2
gene (hACE2), which is the receptor for SARS-CoV-2. The gene hACE2 is inserted to replace the rat Ace2 locus.
The required rat Ace2 knockout as the control strain (rAce2-KO) has also been generated. By comparing these
2 strains, in Aim 1 we will examine the suitability of this rat model for studying COVID-19. Further, based on our
recent published work using germ-free rats indicating that introduction of microbiota to germ-free rats
upregulated colonic Ace2 expression and blood pressure combined with the existing knowledge of a strong
relationship between salt-sensitive hypertension and the gut microbiota; in Aim 2, we will test the hypothesis that
the loss of normal symbiosis between the host and gut microbiota during a hypertensive state is responsible for
the lower ACE2 expression in multiple organs.
7。项目摘要/摘要
动物模型的票价是必不可少的,对于了解Covid-19的病理以及发展
疫苗。它们对于识别COVID-19的病因在有风险的特定群体中,例如
患有预先存在高血压的人。虽然有仓鼠,雪貂,猫,非人类灵长类动物和K18--
HACE2转基因小鼠是研究Covid-19的可能模型,没有一个目的是研究
高血压与对Covid-19的易感性之间的关系,因为(1)野生型研究模型没有
被人类SARS-COV-2和/或(2)感染,它们在遗传上不易高血压。填写这个
未满足的需求,我们建议开发体内实验平台,以研究Covid-19
高血压。在初步数据中,我们提供了开发新型敲门大鼠模型的证据
使用CRISPR/CAS9技术编辑的高血压DAHL盐敏感(S)大鼠表达人ACE2
基因(HACE2),它是SARS-COV-2的受体。插入基因HACE2以替代大鼠ACE2基因座。
所需的大鼠ACE2敲除作为控制菌株(Race2-KO)也已产生。通过比较这些
2菌株,在AIM 1中,我们将研究该大鼠模型对研究Covid-19的适用性。此外,根据我们的
使用无菌大鼠的最新发表的工作表明将微生物群引入无菌大鼠
上调的结肠ACE2表达和血压与现有强大知识相结合
盐敏感性高血压与肠道菌群之间的关系;在AIM 2中,我们将检验以下假设。
高血压状态下宿主和肠道微生物群之间正常共生的丧失是造成的
多个器官中的较低ACE2表达。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gut microbiota of wild fish as reporters of compromised aquatic environments sleuthed through machine learning.
通过机器学习来侦查野生鱼类的肠道微生物群,作为受损水生环境的报告者。
- DOI:10.1152/physiolgenomics.00002.2022
- 发表时间:2022
- 期刊:
- 影响因子:4.6
- 作者:TurnerJr,JohnW;Cheng,Xi;Saferin,Nilanjana;Yeo,Ji-Youn;Yang,Tao;Joe,Bina
- 通讯作者:Joe,Bina
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BINA JOE其他文献
BINA JOE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BINA JOE', 18)}}的其他基金
A novel model to study COVID-19 and Hypertension
研究 COVID-19 和高血压的新模型
- 批准号:
10287008 - 财政年份:2021
- 资助金额:
$ 19.31万 - 项目类别:
Genetic, Epigenetic and Dietary Salt effects on Microbiota and Hypertension
遗传、表观遗传和膳食盐对微生物群和高血压的影响
- 批准号:
9921475 - 财政年份:2018
- 资助金额:
$ 19.31万 - 项目类别:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
新型高血压基因机制研究的创新模型
- 批准号:
8390476 - 财政年份:2011
- 资助金额:
$ 19.31万 - 项目类别:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
新型高血压基因机制研究的创新模型
- 批准号:
8589002 - 财政年份:2011
- 资助金额:
$ 19.31万 - 项目类别:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
新型高血压基因机制研究的创新模型
- 批准号:
8775253 - 财政年份:2011
- 资助金额:
$ 19.31万 - 项目类别:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
新型高血压基因机制研究的创新模型
- 批准号:
8259243 - 财政年份:2011
- 资助金额:
$ 19.31万 - 项目类别:
Innovative Models for Mechanistic Studies of Novel Hypertension Genes
新型高血压基因机制研究的创新模型
- 批准号:
8968260 - 财政年份:2011
- 资助金额:
$ 19.31万 - 项目类别:
相似国自然基金
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
- 批准号:82330111
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
- 批准号:82373169
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
- 批准号:32300137
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
- 批准号:82305216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
- 批准号:32302080
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Potential role of skin in SARS-CoV-2 infection
皮肤在 SARS-CoV-2 感染中的潜在作用
- 批准号:
10593622 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment
研究 α5β1 整合素在 COVID-19 相关认知障碍危险因素中的作用和治疗潜力
- 批准号:
10658178 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Vagal airway sensory nerve activation by beta-coronavirus spike protein
β-冠状病毒刺突蛋白激活迷走神经气道感觉神经
- 批准号:
10748485 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Chitin and chitinases in SARS-CoV-2 infection
SARS-CoV-2 感染中的几丁质和几丁质酶
- 批准号:
10742004 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别: